On 4 July 2024, the European Commission approved GM maize MON810, DP23211 and DP915635 for use in food and feed.

Among them, the transgenic corn MON810 was developed by Bayer in Germany and contains the Cry1Ab gene derived from Bacillus thuringiensis, which has the characteristics of resistance to lepidoptera insects.

Transgenic corn DP23211 was developed by Corteva Company in the United States, containing IPD072Aa gene from Pseudomonas chlororaphis, PAT gene from Streptomyces viriochromogenes and PMI gene from Escherichia coli. It is resistant to coleoptera insects and resistant to phosphine oxalate.

Transgenic corn DP915635 was developed by Corteva Company in the United States, containing PAT gene from Streptomyces viriochromogenes, IPD079Ea gene from Ophioderma pendulum and PMI gene from Escherichia coli. It is resistant to corn rootworm and resistant to phosphine oxalate.

The GMO maize has passed a safety assessment and the authorisation is valid for 10 years, during which time it must comply with strict EU labelling and traceability rules.